Clinical trial
Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
NCT00328302 · Karolinska University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00328302 |
|---|---|
| Title | Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy |
| Official title | Studies of Early Diabetic Glomerulopathy-the Relation Between Histopathology, Kidney Function and Metabolic Control. Natural History and Effect of ARB |
| Lead sponsor | Karolinska University Hospital, Other |
| Collaborators | AstraZeneca Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Type I |
| Intervention type | Drug |
| Interventions | Candesartan, Placebo |
| Enrollment | 13 |
| Start date | Sep 1, 2000 |
| Completion | Apr 1, 2006 |
| First posted | May 19, 2006 |
| Last update posted | May 19, 2006 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: